Anti-tumour effects of Egyptian propolis on Ehrlich ascites carcinoma;Effetti antitumorali della propoli Egiziana sul carcinoma ascitico di Ehrlich

Veterinaria Italiana

Volumn 47, Issue 3, 2011, Pages 341-350

  Badr, Mohamed O T ^a   Edrees, Nariman M M ^a   Abdallah, Amany A M ^a   El Deen, Nasr A M N ^a   Neamat Allah, Ahmed N F ^a   Ismail, Hager T H ^a  

^a Zagazig University   (Egypt)

Author keywords

Biochemical; Cancer; Egypt; Ehrlich ascites carcinoma; Haematology; Immunology; Lymphocyte transformation rate; Propolis; Water soluble propolis derivative

Indexed keywords

PROPOLIS;

ANIMAL; ARTICLE; DRUG SCREENING; EHRLICH ASCITES TUMOR; FEMALE; MOUSE;

ANIMALS; CARCINOMA, EHRLICH TUMOR; DRUG SCREENING ASSAYS, ANTITUMOR; FEMALE; MICE; PROPOLIS;

MUS;

EID: 85075877282     PISSN: 0505401X     EISSN: 18281427     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Bounous D.I., Campagnoli R.P. & Brown J. 1992. Comparison of MTT colorimetric assay and titrated thymidine uptake for lymphocyte proliferation assay using chicken splenocyte. Avian Dis, 36, 1022-1027.
2. Boyse E.A., Old L.J. & Chouroulinkov I. 1964. Cytotoxic test for determination of mouse antibody. Methods Med Res, 10, 39-47.
3. Cabrales L.B., Ciria H.C., Bruzón R.P., Quevedo M.S., Aldana R.H., De Oca L.M., Salas M.F. & Peña O.G. 2001. Electrochemical treatment of mouse Ehrlich tumor with direct electric current. Bioelectromagnetics, 22 (5), 316-322.
4. Coles E H. 1986. Veterinary clinical pathology, 2nd Ed. W.B. Saunders Company, Philadelphia and London, 193-246.
5. DeGowin R.L. & Gibson D.P. 1978. Suppressive effects of an extramedullary tumor on bone marrow erythropoiesis and stroma. Exp Hematol, 6 (6), 568-575.
6. Doumas B.T., Baysa D.D., Carter R.J., Peters T. & Schaffer R. 1981. Determination of serum total protein. Clin Chem, 27, 1642.
7. Drupt F. 1974. Colorimetric method for determination of serum albumin. Pharm Bio Sci, 9, 777.
8. Funasaka T., Haga A., Raz A. & Nagase H. 2002. Tumor autocrine motility factor induces hyperpermeability of endothelial and mesothelial cells leading to accumulation of ascites fluid. Biochem Biophys Res Commun, 293 (1), 192-200.
9. Garrison R.K., Galloway R.H. & Heuser L.S. 1987. Mechanism of malignant ascites production. J Surg Res, 42, 126-132.
10. Goldie H. 1956. Growth characteristic of free tumours cells in various body fluids and tissues of the mouse Ann NY Acad Sci, 63, 711-727.
11. Hashem M.A., Mohamed H.M & Magda S.H. 2004. Clinicopathological, pathological and biophysical studies on the effect of electromagnetic field on the Ehrlich tumour cells implanted in mice. Egypt J Comp Pathol Clin Pathol, 17 (2), 117-147.
12. Havsteen B. 1983. Flavonoids, a class of natural products of high pharmacological potency. Biochem Pharmacol, 32, 1141-1148.
13. Hayashi A., Gillen A.C. & Lott J.R. 2000. Effects of daily oral administration of quercetin chalcone and modified citrus pectin on implanted colon-25 tumour growth in Balb-c mice. Altern Med Rev, 5, 546-552.
14. Husdan H. & Rapoport K. 1968. Chemical determination of creatinine with deproteinization. Clin Chem, 14, 222-238.
15. Mandal A. & Poddar M.K. 2007. Does caffeine reverse the EAC cell-induced immune suppression? J Pharm Pharmacol, 59 (7).1001-1009.
16. Matsuno T., Matsumoto Y., Saito M. & Morikawa J.Z. 1997. Isolation and characterization of cytotoxic diterpenoid isomers from propolis. Z Naturforsch C, 52, 702-704.
17. Munker R. & Andreeff M. 1996. Induction of death (CD95/FAS), activation and adhesion molecules (CD54) on blast cells of acute myelogenous leukemias by TNF-alpha and IFN-gamma. Cytokines Mol Ther, 2, 147-159.
18. Orsolic N., Ivan Kosale I. & Basic I. 2005. Synergystic antitumor effect of polyphenolic components of water soluble derivative of propolis against Ehrlich ascites tumour. Biol Pharm Bull, 28 (4), 694-700.
19. Pezzuto J.M. 1997. Plant-derived anticancer agent. Biochem Pharmacol, 53,121-133.
20. Plowman J., Dykes D.J., Hollingshead M., Simpson-Herren L. & Alley M.C. 1995. Anticancer drug development guide: preclinical screening, clinical trials, and approval. Humana Press Inc., New Jersey, 101 pp.
21. Sforcin J.M. 2007. Propolis and the immune system: a review. J Ethnopharmacol, 113 (1), 1-14.
22. Stuehr D.J. & Nathan C. 1989. A macrophage product responsible for cytostasis and respiratory inhibition in tumour target cells. J Exp Med, 169, 1543-1555.
23. Takagi Y., Choi I.S., Yamashita T., Nakamura T., Suzuki I, Hasegawa T., Oshima M. & Gu Y.H. 2005. Immune activation and radioprotection by propolis. Am J Chin Med, 33, (2), 231-240.
24. Tamhane A.C. & Dunlop D.D. 2000. Statistic and data analysis from elementary to intermediate. Prentice Hall, Upper Saddle River, New Jersey, 85 pp.
25. Tatefuji T., Yamauchi H., Ikeda M., Ando S. & Kurimoto M. 1993. Effect of propolis obtained in Brazil on infectivity of viruses. Nat Med, 47, 60-64.
26. Velikova M., Bankov V., Svelkova I., Kujumgiev A. & Marcucci M. 2000. Antibacterial ent-kaurene from Brazilian propolis stingless bees. Fitoterapia, 71, 693-696.
27. Wleklik M., Zahorska R. & Luczak V. 1997. Interferon-inducing activity of flavonoids. Acta Microbiol Pol, 36, 151-154.
28. Woldehiwet Z. & Rowan T.G. 1990. Some observation on the effects of age on the phagocytosis and killing of S. aureus by polymorphnuclear leucocytes. Br Vet J, 146,165-172.